Allergan's Rapid-Acting Antidepressant Fails in Key Studies - Bloomberg

Submitted by Anonymous (not verified) on Wed, 03/06/2019 - 22:23

Allergan's Rapid-Acting Antidepressant Fails in Key Studies  BloombergAllergan Plc fell after saying its fast-acting depression drug failed to show an improvement in symptoms beyond the placebo effect in three key studies.